Presentation NY Valves 2024 TAVR Will Have a Longer Lasting Durability Than SAVR Presenter: Michael J. Reardon June 06, 2024
Presentation NY Valves 2024 Hemodynamic Performance and Restoration of Laminar Flow Presenter: Michael J. Reardon June 05, 2024
Presentation NY Valves 2024 The Lifetime Management of Aortic Stenosis: A Heart Team Perspective Presenter: Michael J. Reardon June 05, 2024
News Conference News STS 2024 Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3 Yael L. Maxwell February 09, 2024
News Conference News PCR London Valves 2023 Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge Shelley Wood November 27, 2023
Presentation TCT 2023 Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR) Presenter: Michael Reardon October 25, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
Presentation TCT 2023 Four-Year Outcomes From the EVOLUT Low Risk Trial Presenter: Michael Reardon October 24, 2023
Presentation TCT 2023 China Experiences with J-Valve TAVR for Both Aortic Regurgitation and Stenosis Presenter: Michael Reardon October 23, 2023
News Daily News ‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease Michael O'Riordan September 13, 2023
News Conference News CRT 2023 New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR Yael L. Maxwell March 03, 2023
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023
News Conference News TCT 2022 Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year L.A. McKeown September 23, 2022
News Conference News TCT 2022 Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances Caitlin E. Cox September 19, 2022
News Conference News TCT 2022 Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning Shelley Wood September 19, 2022
Presentation TCT 2022 Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR? Presenter: Michael Reardon September 19, 2022
Presentation TCT 2022 Portico with FlexNav Introduction & Current Data Presenter: Michael Reardon September 17, 2022
News Conference News TVT 2022 Surgical Explant or Redo for TAVI Failures? Some Registry Insights Michael O'Riordan June 10, 2022
Presentation TVT 2022 POINT: The Interaction Between Echo Hemodynamics and Structural Aortic Valve Deterioration Presenter: Michael J. Reardon June 09, 2022